32 ms·
Pfizer-BioNTech Covid-19 vaccine and myocarditis in individuals aged 16-29 years [pdf]
- a9h74j 5y agoGood that they are addressing risk/benefits. Offhand I see no breakout for what extra-risk groups the hospital deaths with Covid might have involved. If these were confined to specific subpopulations, the risk benefit analysis for those not in such a subpopulation, could differ.